Letter/Communication
Hope for Managing Epistaxis in Hereditary Hemorrhagic Telangiectasia
NEJM journal watch. Oncology & hematology
09/27/2024
Abstract
A randomized, placebo-controlled study provides evidence that pomalidomide is an effective treatment with an acceptable safety profile for reducing nosebleed severity.
Details
- Title: Subtitle
- Hope for Managing Epistaxis in Hereditary Hemorrhagic Telangiectasia
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 09/27/2024
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984721236402771
Metrics
5 Record Views